16 results
management hivaids opportunistic prevention treatment diabetes dm2 agonists glp1 mycobacterium summary antibiotics aviumcomplex bartonella bartonellosis capsulatum chagas cmv coccidiodomycosis cryptococcosis
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... (ER version) ... side effects (e.g ... Receptor #Agonists #Pharmacology ... DM2 #diabetes #endocrinology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicillium marneffei Infections ... amphotericin B, 3 to 5 mg/kg ... Penicilliosis #IDSA ... #HIVAIDS #pharmacology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... hypovolemia) • GU infections ... (e.g. ... SGLT2 #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
IDSA Recommendations ... ., 4 mg/kg on days ... dose of 20–60 mg/kg ... opportunistic #infections ... #HIVAIDS #pharmacology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
Bydureon (Exenatide ER ... are subcutaneous injections ... GI tract) and injection ... GLP1 #Agonists #Pharmacology ... Diabetes #DM2 #Endocrinology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
IDSA Recommendations ... Nifurtimox 8–10 mg/kg ... Trypanosomiasis #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... amphotericin B 3–5 mg/kg ... deoxycholate 0.7–1.0 mg/kg ... Coccidiodomycosis #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
IDSA Recommendations ... Cytomegalovirus Infections ... other factors (e.g ... Cytomegalovirus #CMV #IDSA ... #HIVAIDS #pharmacology
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... Foot Infections ... infected tissue (eg ... Diabetic #Foot #Infections ... #antibiotics #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Simplex Virus (HSV) Infections ... acyclovir 5 mg/kg ... HerpesSimplex #HSV #IDSA ... #HIVAIDS #pharmacology
No results found for "ER ekg pharmacology medstudent infections idsa endocrinology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ER #ekg #pharmacology #medstudent #infections #idsa #endocrinology